Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
Nexo Therapeutics offers treatments for some of cancer's most intractable targets.
Myra Vision develops a treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
ConnectRN is a tech-enabled network built to improve clinicians' lives through access to community, opportunity, and support.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Bliss Bio is a biopharmaceutical company focused on development of tumor targeting and immunotherapy drugs.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
MOMA Therapeutics operates as a biotechnology company.
Arkuda Therapeutics is a pharmaceutical company.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
Stablix Therapeutics is a biotechnology company pioneering the field of Targeted Protein Stabilization (TPS).
NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies
Renovia was a developer of prescription digital therapeutics for pelvic floor disorders. Renovia ceased operations in late 2022.
Graphite Bio is a next-generation gene editing company that is driven to apply our breakthrough technology.
Cormorant Asset Management has invested in 205 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cormorant Asset Management's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Life Science. The firm invests across 21 different industry categories.
Among tracked funding rounds, Pliant Therapeutics received $287.5M in a Post Ipo Equity round. Cormorant Asset Management's total known invested capital is $18.6B.
Cormorant Asset Management's average investment size is $120.0M across its portfolio of 205 companies.
Recent Cormorant Asset Management portfolio additions include Synnovation Therapeutics, Verve Therapeutics, Harpoon Therapeutics, Nexo Therapeutics, Myra Vision. These companies were founded in 2020 or later.